Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Epilepsy | D004827 | EFO_0000474 | G40.9 | — | 2 | 3 | — | — | 4 |
Seizures | D012640 | — | G40.4 | — | 2 | 1 | — | — | 2 |
Partial epilepsies | D004828 | EFO_0004263 | — | — | 2 | 1 | — | — | 2 |
Drug common name | Seletracetam |
INN | seletracetam |
Description | Seletracetam (UCB 44212) is a pyrrolidone-derived drug of the racetam family that is structurally related to levetiracetam (trade name Keppra). It was under development by UCB Pharmaceuticals as a more potent and effective anticonvulsant drug to replace levetiracetam but its development has been halted.
|
Classification | Small molecule |
Drug class | nootropic agents (learning, cognitive enhancers), piracetam type |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@@H](C(N)=O)N1C[C@H](C=C(F)F)CC1=O |
PDB | — |
CAS-ID | 357336-74-4 |
RxCUI | — |
ChEMBL ID | CHEMBL3918017 |
ChEBI ID | — |
PubChem CID | 9856063 |
DrugBank | DB05885 |
UNII ID | RFR2CH3QZK (ChemIDplus, GSRS) |